$58.61
0.97% today
Nasdaq, May 21, 05:22 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Stock price

$59.18
+5.75 10.76% 1M
-33.52 36.16% 6M
-21.34 26.50% YTD
-9.52 13.86% 1Y
+22.17 59.90% 3Y
+17.24 41.11% 5Y
+17.24 41.11% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.11 0.19%
ISIN
US74276L1052
Symbol
PRCT
Sector

Key metrics

Market capitalization $3.27b
Enterprise Value $3.04b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 12.19
P/S ratio (TTM) P/S ratio 13.14
P/B ratio (TTM) P/B ratio 8.41
Revenue growth (TTM) Revenue growth 59.37%
Revenue (TTM) Revenue $249.12m
EBIT (operating result TTM) EBIT $-96.40m
Free Cash Flow (TTM) Free Cash Flow $-88.21m
Cash position $316.21m
EPS (TTM) EPS $-1.64
P/E forward negative
P/S forward 10.09
EV/Sales forward 9.36
Short interest 14.10%
Show more

Is PROCEPT BioRobotics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,786 stocks worldwide.

PROCEPT BioRobotics Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a PROCEPT BioRobotics forecast:

Buy
82%
Hold
18%

Financial data from PROCEPT BioRobotics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
249 249
59% 59%
100%
- Direct Costs 93 93
28% 28%
37%
156 156
87% 87%
63%
- Selling and Administrative Expenses 187 187
32% 32%
75%
- Research and Development Expense 66 66
29% 29%
26%
-91 -91
13% 13%
-36%
- Depreciation and Amortization 5.53 5.53
32% 32%
2%
EBIT (Operating Income) EBIT -96 -96
11% 11%
-39%
Net Profit -90 -90
13% 13%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about PROCEPT BioRobotics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PROCEPT BioRobotics Stock News

Positive
Market Watch
4 days ago
Industrial robots have been around for decades. They're often used on manufacturing lines, where they perform automated tasks.
Neutral
GlobeNewsWire
22 days ago
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at four upcoming investor conferences in May and June.
Neutral
GlobeNewsWire
27 days ago
Presentations underscore long-term clinical outcomes, safety  and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT)  (“PROCEPT”), a surgical robotics company whose mission is to revolutionize BPH treatment globally, today announced an exte...
More PROCEPT BioRobotics News

Company Profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Reza Zadno
Employees 756
Founded 2007
Website www.procept-biorobotics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today